Hereditary Cancer Syndromes: Identifying and Treating Patients at Risk - JA0008057-0000-19-239-H01-P

Hereditary Cancer Syndromes: Identifying and Treating Patients at Risk

by Nancy Ledbetter, MSN, RN, CNS, APNG, AOCNS
JA0008057-0000-19-239-H01-P
(4.7 / 3 ratings )

This course is credentialed for:
Pharmacy (1.75 Contact Hr)

Summary:

Family history has long been an established risk factor for cancer. Family history influences cancer risk in many ways. Families share genes, but they also tend to share habits and environments that create disease clusters among relatives. A small subset (5% to 10% of all cancers) are due to a hereditary syndrome. Genetic tests have been developed and are in use for at least 50 known hereditary cancer syndromes. People with hereditary cancer syndromes benefit from strategies aimed at prevention, early detection through surveillance, and improved cancer treatment. Genetic testing for hereditary predisposition to cancer, and knowledge of the resultant impact on medical care, are rapidly evolving. Genetic testing for hereditary cancer risk has become the standard of care in many clinical circumstances.     

Objectives:

The goal of this continuing education program is to enhance healthcare providers’ understanding of hereditary cancer syndromes, with emphasis on two of the most common syndromes: hereditary breast/ovarian cancer syndrome (HBOC caused by BRCA1 and BRCA2 gene mutations) and hereditary colon cancer, including Lynch syndrome and polyposis (multiple polyps). After studying the material presented here, you will be able to:
  • List three goals of genetic testing for hereditary cancer syndromes
  • Name three cancers for which there are effective prevention and/or screening interventions for patients at high hereditary risk
  • Identify three limitations of genetic testing for hereditary cancer syndromes
  • Discuss how the interprofessional healthcare team should collaborate to promote educational goals related to three hereditary cancer syndromes
 

 
Accreditation Information
 
This course is intended for an interprofessional audience, including nurses, dietitians, pharmacists and physicians.
 
Pharmacists: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at ContinuingEducation.com or Nurse.com/CE. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at CEDirect.ContinuingEducation.com and search for this topic title.
 
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
OnCourse Learning is also approved by the Florida Board of Pharmacy (provider # 50-1489).
 
Type of Activity: Knowledge
 
Initial Release Date: 03/01/2019; Planned Expiration Date: 12/31/2019
 
Hours dedicated to pharmacology: 0.75 contact hour